Dr Daryl Tan is a haematologist at Mount Elizabeth Novena Hospital, Singapore.
He trained in internal medicine and haematology at the Singapore General Hospital, and pursued postdoctoral training and clinical research in the field of lymphoma at Stanford University, USA.
He was formerly the clinical lead for the lymphoma and myeloma services at the Singapore General Hospital, and spearheaded several clinical trials examining novel approaches in treating lymphoma and multiple myeloma.
In 2011, Dr Tan helped set up a comprehensive haematology service and was the director of research at a private hospital in Singapore. He integrated research with clinical practice, availing novel therapeutics for cancer patients failing standards of care.
He was an assistant professor at the Duke-NUS Graduate Medical School, and received several research grants from the National Medical Research Council, Singapore Health Foundation, and the Singapore Cancer Syndicate.
He was elected into the International Myeloma Working Group in 2014 and also sits on the advisory panel of the International Myeloma Foundation’s Asia Myeloma Network. He has delivered more than 80 invited lectures on the treatment of lymphoma and multiple myeloma at international and regional conferences.
Dr Tan is a board member of the Chapter of Haematologists and is appointed by the Ministry of Health as an advisor for the Residency Advisory Committee for Haematology training in Singapore. His continued affiliation with the academic hospitals allows him to contribute to post-graduate teaching, and to advise patients on participation in clinical trials for lymphoma and multiple myeloma.
He was the principal investigator of more than 40 investigator-initiated and industry-sponsored clinical studies. His research has led to several international presentations and more than 100 publications in high-impact factor scientific journals including first-authored articles in the Lancet Oncology, Blood and the Annals of Oncology.
His expertise in lymphoma and multiple myeloma was recognised by the publication of two lead-author review articles on their respective treatment guidelines in Lancet Oncology in 2014. Dr Tan’s work on immunotherapy in NK/T-cell lymphoma has led to its endorsement on the American NCCN cancer treatment guidelines in 2018.
Dr Tan has received several awards including the Singapore Health Service Quality Service Gold Award in 2011 and the Courage Medal during the Singapore SARS epidemic in 2004.
Bachelor of Medicine, Bachelor of Surgery, Singapore
Member of the Royal College of Physicians, UK
Master of Medicine (Internal Medicine)
Fellow of the Academy of Medicine, Singapore